Abstract
The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality and morbidity, and expenditure. However, clinicians lack knowledge of EA and thus often prescribe inappropriate management. In this review, we ask 3 key questions frequently encountered during EA diagnosis and treatment: 1) Is EA different?; 2) How can we appropriately diagnose EA?; 3) Are there management strategies specific to EA? Based on recent studies, we provide tentative answers as follows: 1) late-onset EA differs in clinical features and pathogenetic mechanisms from non-EA, and thus further phenotypic and endotypic characterization of EA is needed; 2) both over- and under-diagnosis of asthma in the elderly can be reduced if the objective diagnostic tests are appropriately performed; 3) cautious prescription of ICS to selected EA patients should be encouraged, and a multifaceted approach which involves increasing medical awareness and inhaler use proficiency and adherence, seeking the assistance of caregivers, and correcting micronutrient deficiencies is required to reduce acute exacerbations in EA patients.
Original language | English |
---|---|
Pages (from-to) | 8-18 |
Number of pages | 11 |
Journal | Allergy, Asthma and Immunology Research |
Volume | 15 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2023 |
Bibliographical note
Publisher Copyright:Copyright © 2023 The Korean Academy of Asthma.
Keywords
- Asthma
- aged
- asthma-COPD overlap syndrome
- diagnosis
- immunosenescence
- integrative medicine
- therapeutics